Enhanced detection of phosphopeptides in matrix-assisted laser desorption/ionization mass spectrometry using ammonium salts  by Asara, John M. & Allison, John
Enhanced Detection of Phosphopeptides in
Matrix-Assisted Laser Desorption/Ionization
Mass Spectrometry Using Ammonium Salts
John M. Asara and John Allison
Department of Chemistry, Michigan State University, East Lansing, Michigan, USA
Matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS) has been used
successfully to detect phosphorylation sites in proteins. Applications may be limited by the
low response of phosphopeptides compared to nonphosphorylated peptides in MALDI MS.
The addition of ammonium salts to the matrix/analyte solution substantially enhances the
signal for phosphopeptides. In examples shown for equimolar mixtures, the phosphorylated
peptide peaks become the largest peaks in the spectrum upon ammonium ion addition. This
can allow for the identification of phosphopeptides in an unfractionated proteolytic digestion
mixture. Sufficient numbers of protonated phosphopeptides can be generated such that they
can be subjected to postsource decay analysis, in order to confirm the number of phosphate
groups present. The approach works well with the common MALDI matrices such as
a-cyano-4-hydroxycinnamic acid and 2,5-dihydroxybenzoic acid, and with ammonium salts
such as diammonium citrate and ammonium acetate. (J Am Soc Mass Spectrom 1999, 10,
35–44) © 1999 American Society for Mass Spectrometry
Protein phosphorylation is probably the singlemost common and important reversible intracel-lular signal transduction event [1]. Understand-
ing the regulation of protein function by phosphoryla-
tion/dephosphorylation is a key objective in many
areas of biomedical research, including studies involv-
ing cell cycle regulation, enzyme activation/deactiva-
tion, and protein–protein association. Phosphorylation
serves other functions as well in protein chemistry.
Protein-bound phosphate may serve to maintain the
structure of an enzyme without regulating its activity
[2]. Also, as in the classic cases of those found in egg
yolk and milk, phosphoproteins serve as stores of
phosphate and bound metal ions [2].
Direct analytical methods to identify phosphoryla-
tion sites of proteins of known sequence, at or below the
picomole level, are critical to these research areas. Mass
spectrometry has played an essential role in mapping
posttranslational modifications of proteins such as
phosphorylation [3]. Both matrix-assisted laser desorp-
tion/ionization mass spectrometry (MALDI MS) [1,
3–6] and electrospray ionization mass spectrometry
(ESI MS) [3, 7, 8] have been used effectively, each with
its strengths and limitations.
Suppose a protein P is multiply phosphorylated. One
approach to locate the phosphorylation sites is to first
subject P to a proteolytic digestion using, typically,
trypsin. The set of degradation products {Di} may be
analyzed in a “batch” method. That is, all of the
products can be analyzed simultaneously using MALDI
[4, 6]. If the mixture is complex, high-performance
liquid chromatography (HPLC) can be used to fraction-
ate the mixture. Fractions can be collected and each
subjected to MALDI analysis [1, 6, 9], or the HPLC
effluent can be analyzed directly using ESI MS. Elegant
methods for locating phosphorylated fragments and
determining the site of the modification using HPLC/
ESI MS have been described in the literature [10–14]. If
HPLC fractions are collected for subsequent MALDI
analysis, incorporation of 32P labeling can be used to
indicate which Di’s are phosphopeptides [9]. Mass
mapping techniques [6, 15] are commonly used to
predict the mass-to-charge ratio values of the proton-
ated proteolytic digestion products. If a peak is ob-
served in a MALDI mass spectrum which is 80 Da
higher than a predicted peak, it may indicate phosphor-
ylation. If multiple phosphorylations are present, a
mass shift of 80 for each will be observed. The 80 Da
shift corresponds to addition of HPO3 to the –OH group
of a serine, threonine, or tyrosine residue. To confirm
the presence of the phosphate group, a portion of the
sample can be treated with an enzyme such as alkaline
phosphatase [6]. If the peak observed truly represents a
protonated phosphopeptide, its mass will decrease (by
80 u) upon enzymatic dephosphorylation.
In MALDI MS, an analyte peptide M will usually
yield a peak representing [M 1 H]1 ions. However, in
the direct analysis of a mixture of several peptides, such
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as those encountered in digestions, peaks for all com-
ponents are usually not observed—and certainly not
with equal intensities for equally abundant compo-
nents. One reason for this has been attributed to sup-
pression effects [16, 17], in which the presence of one
peptide inhibits the response for another. Thus, some
form of fractionation would seem reasonable to use,
although time consuming, prior to MALDI MS analysis
of digestion mixtures. The situation is particularly prob-
lematic when phosphopeptides are present. Liao et al.
[6] have shown that the desorption/ionization efficien-
cies for phosphopeptides in MALDI MS are approxi-
mately an order of magnitude lower than for the
nonphosphorylated forms [5]. The situation is worse
when more than one phosphate group is present [6].
These facts limit the utility of MALDI MS for the
identification of phosphorylation sites. If one uses the
trypsin/alkaline phosphatase combination, and a pep-
tide containing three phosphates is encountered, for
example, no signal may be detected for the intact
analyte. When the phosphates are removed, the de-
phosphorylated form may be detected, but without
knowing the mass-to-charge ratio values before and
after dephosphorylation, the number of phosphoryla-
tion sites cannot be determined.
Why do phosphorylated peptides exhibit low re-
sponse in MALDI? Presumably the presence of the
phosphate group is exhibiting a direct influence. This
group exists in solution in an anionic form. If the
peptide skeleton is considered in its neutral form, each
phosphate group can carry up to two charges. If a
multiply charged analyte is trapped in the MALDI
matrix crystals in ionic form, insufficient energy is
available in the MALDI experiment for the direct de-
sorption of multiply charged species. For most analytes,
singly charged ions are predominantly formed [18]. A
tetraphosphorylated protein fragment could hold a
charge of 28; certainly the 28 form of the ion would not
be generated in the gas phase in the MALDI experi-
ment. If a low energy chemical pathway does not exist
that allows the analyte to lower its charge, then no
signal will be observed [18]. Similar considerations have
been discussed in the analysis of multiply charged
anionic [19] and cationic [20] analytes in the fast atom
bombardment (FAB) MS experiment.
This paper discusses the use of matrix additives in
the MALDI experiment to allow for improved detection
of phosphopeptides. Oligonucleotides have been suc-
cessfully analyzed in MALDI MS [21–24]; these analytes
contain a high density of negatively charged phosphate
groups, and can carry a substantial accumulated charge
in solution. In this field of research, ammonium salts
such as ammonium acetate or diammonium citrate are
routinely added, and appear to lower the charge on the
analyte [22–24], making detection possible. A basic
model describing the influence of ammonium ions has
been proposed [25]. Ammonium cations complex with
negatively charged groups to form (NH4
1)n (phosphate
2n).
Either prior to or during the desorption/ionization
(D/I) process, ammonia is lost, leaving the charged
group in a neutral form containing protons as the
counter ions, (H1)n (phosphate
2n). It should be noted
that ammonium ions have been implicated as being
protonating (ionizing) agents in the MALDI experiment
as well [24]. We will show here that such additives,
when used correctly, dramatically improve the desorp-
tion/ionization efficiency for phosphopeptides in
MALDI. The enhanced response in both positive and
negative ion mode suggests that citrate ions scavenge
alkali ions [23], to limit their access to phosphate
groups, whereas the ammonium ions serve to ulti-
mately generate the analyte in neutral form. With the
phosphopeptide available in neutral form, it can be
protonated or deprotonated as are most unmodified
peptides in the MALDI experiment.
This paper demonstrates the utility of matrix addi-
tives with common MALDI matrices for the analysis of
single and multiply phosphorylated peptides, both as
pure analytes and in complex mixtures. Conditions are
presented that can lead to the preferential detection of
phosphorylated peptides in a digestion mixture. With
multiply phosphorylated peptides, signals can be en-
hanced to levels that allow for MS/MS experiments to
be performed.
Experimental
Materials
Bradykinin, b-casein, equine myoglobin, angiotensin I,
and angiotensin III were purchased from Sigma Chem-
ical (St. Louis, MO). The phosphopeptides LKRApSLG-
amide and LKRApTLG-amide were purchased from the
University of Michigan Protein and Carbohydrate Fa-
cility (Ann Arbor, MI). Peptides and proteins were used
as supplied without further desalting or purification.
Trypsin was purchased from Promega (Madison, WI).
A four component equimolar mixture of the peptides
LKRApSLG-amide, LKRApTLG-amide, angiotensin III,
and bradykinin was prepared in 1:1 acetonitrile(ACN)/
water at a concentration of 1 pmol/mL (mixture I) and
diluted to 500 and 100 fmol/mL. Another four compo-
nent mixture of the peptides LKRApSLG-amide,
KIGEGpTpYGVVYK, angiotensin I, and angiotensin III
was prepared in 1:1 ACN/H2O at a concentration of 1
pmol/mL (mixture II) and further diluted to 100 fmol/
mL. A two component mixture of b-casein and equine
myoglobin was prepared at a concentration of 10
pmol/mL in 1:1 ACN/H2O (mixture III). The matrix
used for mixtures I and II was a saturated solution of
a-cyano-4-hydroxycinnamic acid (4-HCCA) (Sigma
Chemical) in 1:1 ACN/H2O. For mixture III, a saturated
solution of 2,5-dihydroxybenzoic acid (DHB) (Sigma
Chemical) was employed. In cases where diammonium
citrate (J.T. Baker, Phillipsburg, NJ) or ammonium ace-
tate (Sigma Chemical) was used as an additive, a 1 mM
solution and a 25 mM solution, respectively, was pre-
pared in 1:1 ACN/H2O. In the text, citric acid will be
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referred to as H3Cit, so diammonium citrate will be
designated as (NH4)2HCit. An incomplete tryptic digest
of b-casein was performed in 40% ACN with a 20:1
excess of b-casein to trypsin. The digest was performed
in a 60 mM NH4HCO3 (Sigma Chemical) buffer (pH 5
8.2) and allowed to incubate at 40 °C for 24 h. The
reaction was terminated using formic acid (J.T. Baker).
A 10 mL 1:1 ACN/H2O solution was saturated with
4-HCCA and the pH measured with an Accumet model
15 pH meter, yielding an average value of 2.45.
Mass Spectrometry
Linear MALDI mass spectra were recorded on a Per-
Septive Biosystems (Framingham, MA) Voyager Elite
delayed extraction time-of-flight reflectron mass spec-
trometer equipped with a nitrogen laser (337 nm, 3 ns
pulse). For mixtures I and II and the tryptic digest, the
accelerating voltage in the ion source was 20 kV, the
delay time used was 50 ns, the grid voltage was set to
93.0% of the accelerating voltage, and the guide wire
voltage was set to a magnitude of 0.25% of the acceler-
ating voltage. For mixture III, the accelerating voltage in
the ion source was 21.5 kV, the delay time used was 100
ns, the grid voltage was 92.0% of the accelerating
voltage, and the guide wire voltage was set at 0.25%.
Typically, 128–256 laser shots were averaged for each
spectrum. The sample stage used was a gold sample
plate capable of holding 100 targets. The postsource
decay (PSD) experiment was performed in the reflec-
tron mode with an accelerating voltage of 21 kV, delay
time of 100 ns, grid voltage of 70.0%, and guide wire
voltage of 0.15%. The timed ion selector was set at m/z
3124 and three spectra, with mirror voltage:accelerating
voltage ratios of 1.00, 0.96, and 0.67, were stitched
together to obtain the PSD spectrum.
Sample Preparation
Targets were prepared by mixing 1 mL of analyte and 1
mL of matrix on a sample stage and allowing them to air
dry. When ammonium additives were used, 1 mL of the
ammonium salt solution was also mixed with analyte
and matrix solutions on the sample stage.
For the experiment involving a PVDF membrane
(Millipore, Bedford, MA), 1 mL of the 1 pmol/mL
mixture I was spotted onto the membrane and allowed
to air dry. The saturated matrix was then introduced by
the perfusion method described by Strahler et al. [26].
Two pieces of filter paper cut in rectangular strips were
loaded into a shallow well and sealed on the bottom
and all four sides. The filter paper was saturated with
matrix. A piece of PVDF membrane carrying analyte,
identical in size to the filter paper, was then placed on
the filter paper stack such that the matrix solution could
only evaporate through the membrane surface. The
membrane containing matrix crystals was then intro-
duced to the MALDI instrument by placing a fine
conducting grid on top, as described previously [26].
When an ammonium salt was used, it was introduced
again by the perfusion method—a mixture of saturated
4-HCCA and 25 mM diammonium citrate (1:1 ratio)
was used to saturate the filter paper in this experiment.
Results and Discussion
We show here that the addition of (NH4)2HCit to the
MALDI matrix/analyte target solution just prior to
crystal formation leads to enhanced detection of phos-
phopeptides. The enhancements shown were observed
upon addition of other ammonium salts such as ammo-
nium acetate, but the influence of the citrate salt is
greater. Also, experiments were performed at a variety
of matrix:additive:analyte ratios. Although the effects
shown can be realized with addition of diammonium
citrate using millimolar to micromolar concentrations,
we believe that introduction of 1 mL of a 1 mM
diammonium citrate solution to the MALDI target
solution (1 mL matrix solution11 mL analyte) works
well when the matrix is 4-HCCA, whereas use of a 25
mM additive solution works well when the matrix is
DHB. These are suggested ammonium salt concentra-
tions for the matrices tested, and for the analysis of
phosphopeptides in the femtomole to low picomole
range. The fact that different concentrations are re-
quired for different matrices may be related to the
varying matrix compound solubilities.
Figure 1a shows the positive ion MALDI spectrum of
a 4-component peptide mixture (mixture I) using
4-HCCA as the matrix. Each component is present at a
level of 500 fmol. Two components are clearly detect-
ed—the peak at m/z 917.5 represents protonated angio-
tensin III molecules, and the peak at m/z 1060.6 repre-
sents protonated bradykinin molecules. All mass-to-
charge ratio values represent monoisotopic masses
unless otherwise indicated. The other two components
present are singly phosphorylated peptides, and exhibit
substantially smaller signals. The peak for protonated
LKRApSLG-amide is observed at m/z 823.5 and that
for LKRApTLG-amide is at m/z 837.5; both are barely
detectable above the noise. This example shows typical
relative responses for singly phosphorylated peptides
relative to nonphosphorylated peptides of similar mass.
When the target crystals are grown with inclusion of
(NH4)2HCit, the same sample yields the spectrum
shown in Figure 1b. The increase in intensity and
signal-to-noise ratio for the peaks representing the
phosphorylated peptides is typical of our experience
using this additive. The phosphate-containing peptides
now yield the most intense peaks in the spectrum.
Figure 1c shows the spectrum following addition of
(NH4)2HCit, where each analyte is present at the 100
fmol level. Again, the phosphorylated components are
clearly detectable, whereas they are not detectable
when the additive is not used.
Although not the point of this paper, a comment
should be made on the influence of this additive in
negative ion mode. When analytes are negatively
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charged in solution, mass spectrometrists frequently
turn to negative ion modes of mass spectrometry anal-
ysis when desorption/ionization techniques such as
FAB and MALDI are used. Small signals are observed
for phosphorylated peptides in the negative ion mode
of MALDI MS, however their intensities greatly in-
crease when diammonium citrate is added, similar to
that observed in positive ion mode. This suggests a
common, neutral form of the analyte, as a starting point
in the ionization chemistry, which can be protonated or
deprotonated to yield cationic and anionic gas phase
ions.
Multiply phosphorylated peptides exhibit low re-
sponses in MALDI, and the effect of diammonium
citrate addition is also dramatic. This is shown using
mixture II. Figure 2a shows the positive ion MALDI
mass spectrum of a four component equimolar mixture
of peptides (1 pmol/peptide). The peaks representing
protonated angiotensin III (m/z 917.5) and angiotensin
I (m/z 1296.7) are the only clearly visible peaks in the
spectrum. For comparison with results from Figure 1,
LKRApSLG-amide is a component (m/z 823.5). The
fourth component is the diphosphorylated peptide
KIGEGpTpYGVVYK (m/z 1474.7). Figure 2b shows the
MALDI spectrum of the same mixture after the addition
of diammonium citrate. The monophosphorylated and
diphosphorylated peptide components are now detect-
able, and these peaks are the most intense. A compari-
son of pairs of spectra, with and without the additive,
clearly indicates which components are phosphory-
lated. Also of note is the decrease in the relative
intensities of the metal ion adducts. The peak represent-
ing protonated angiotensin III is accompanied by an
[M 1 Na]1 peak (m/z 939.5) and an [M 1 Cu]1 peak
(m/z 979.4) in Figure 2a. The 4-HCCA matrix has been
cited as one that “seems to encourage copper attach-
ment to some peptides” [27]. Metal ion adducts are also
present for angiotensin III. The intensities of the metal
ion adducts of these species, relative to the protonated
forms, decrease upon ammonium ion addition. Similar
effects have been observed in DNA fragment analysis
using MALDI, when ammonium salts are added [22–
24] or when ammonium-charged ion exchange beads
are used [21]. Similar to the data in Figure 1, if the
analysis of this mixture is performed at the 100 fmol
level, the diphosphorylated peptide does not yield a
discernible peak. However addition of (NH4)2HCit re-
sults in a peak at m/z 1474.7 with a signal-to-noise
(S/N) ratio greater than 6:1.
Membranes such as PVDF are frequently used in the
analysis of proteins and peptides. Samples can be
directly applied, and the membrane then washed to
remove salts, buffers, contaminants, etc. Also, proteins
Figure 1. MALDI mass spectra of mixture I in (a) a-cyano-4-
hydroxycinnamic acid and (b, c) a-cyano-4-hydroxycinnamic acid
with addition of diammonium citrate.
Figure 2. MALDI mass spectra of mixture II in (a) a-cyano-4-
hydroxycinnamic acid and (b) a-cyano-4-hydroxycinnamic acid
with addition of diammonium citrate.
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or digested protein fragments can be electroblotted
from polyacrylamide gels onto membranes. MALDI
mass spectra can be obtained directly from membranes
[26, 28–31], and (NH4)2HCit has the same effect. When
the peptide mixture used to generate the data shown in
Figure 1 was applied to a PVDF membrane, similar
enhancements and displacement of metal ions were
observed (data not shown). In work with membranes, a
perfusion approach is used. The membrane is placed on
a stack of wet filter paper containing the matrix solu-
tion. A mask prohibits solvent evaporation from any-
where except the membrane surface. As matrix and
solvent pass through the membrane, solvent evaporates
from the “top” side, where matrix crystals grow. This
perfusion approach appears to increase analyte avail-
ability for incorporation into the matrix crystals. When
ammonium salts are used, they can be introduced
simultaneously with the matrix by this perfusion ap-
proach.
The influence of (NH4)2HCit as a MALDI matrix
additive is also observed when larger numbers of
phosphates per peptide are encountered, and for spe-
cies of higher mass. The pentaphosphorylated peptide
b-casein has an average mass-to-charge ratio for [M 1
H]1 of 23,984.3. Although it can be detected using
MALDI [32], without the use of additives, the response
is low. Also, its response can be suppressed by the
presence of other high molecular weight analytes. For
example, even at a level of 10 pmol, b-casein cannot be
detected in the presence of an equimolar amount of
equine myoglobin (avg. mass-to-charge ratio for [M 1
H]1 16,951.7). This is shown in Figure 3a, using DHB as
the matrix, for mixture III. DHB was chosen because it
gives good results for high mass peptides and proteins
in our laboratory. When 1 mL of a 25 mM solution of an
ammonium salt is added, the spectrum in Figure 3b is
obtained. The pentaphosphorylated peptide is now
clearly detectable. To obtain the data in Figure 3b,
ammonium acetate was used. In many situations, the
acetate is as effective as the citrate salt.
A comment should be made on changes in ion
intensities when ammonium salts are added. The data
shown here are typical of our experiences to date, in
that the relative intensities of peaks representing phos-
phorylated peptides increase upon addition of the ad-
ditive. In some cases, this represents a real increase in
peak intensity. In other cases, the absolute intensities of
all of the peaks may increase or decrease. We note that
Woods et al. reported the observation that ammonium
salts can influence the response for nonphosphorylated
peptides in MALDI as well [33]. It is not our intention to
suggest that absolute intensities for phosphorylated
peaks alone will always increase upon addition of
ammonium salts.
At this point a comment should be made on a
common additive in MALDI, trifluoroacetic acid (TFA).
TFA is frequently added to increase the solubility of
polypeptides. TFA presumably changes the pH of the
droplet from which crystals are formed, however it is
also volatile. Acid hydrolysis is always possible when
acidic solutions are used, and it is known that TFA
reacts with amino groups of peptides [27], so it should
be used with caution. However, studies which mea-
sured relative responses for phosphorylated and non-
phosphorylated forms of peptides, showing lower D/I
efficiencies for the phosphorylated forms, were per-
formed using TFA [5, 6]. Although TFA was not used in
the experiments presented here, it should be made clear
that the addition of diammonium citrate or ammonium
acetate to the matrix/analyte sample also works well in
the presence of TFA.
If the products of a proteolytic digestion of a phos-
phopeptide are analyzed as a mixture in a single
MALDI experiment, the phosphorylated fragments
yield small peaks [5, 6]. Addition of ammonium citrate
will enhance their relative intensities, confirming their
assignments as containing one or more phosphate
groups. This is very helpful in extracting targeted
information. The mass spectrometrist need not spend
time interpreting peaks representing fragments which
do not contain phosphorylation sites, when posttrans-
lational modifications are the structural information
desired. It is critical that this additive enhances the
response for multiply phosphorylated polypeptides,
Figure 3. MALDI mass spectra of 10 pmol/component of mix-
ture III in (a) 2,5-dihydroxybenzoic acid and (b) 2,5-dihydroxy-
benzoic acid with addition of ammonium acetate.
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because phosphoserine resides frequently are found in
chains [2]; thus, multiply phosphorylated tryptic frag-
ments of large phosphoproteins are to be expected. For
example, shown here is the sequence of b-casein [2, 6].
Its five phosphorylation sites are indicated (all serine
residues), and sites of cleavage by trypsin are desig-
nated by slashes (\).
1 R\ELEELNVPG EIVEpSLpSpSpSE ESITR\
26 INK\K\I EK\FQpSEEQQQ TEDELQDK\IH
51 PFAQTQSLVY PFPGPIHNSL PQNIP
76 PLTQT PVVVPPFLQP EVMGVSK\VK\E
101 AMAPK\HK\EMP FPK\YPVEPFT ESQSL
126 TLTDV ENLHLPLPLL QSWMHQPHQP
151 LPPTVMFPPQ SVLSLSQSK\V LPVPQK
176 K\AVPY PQR\DMPIQAF LLYQEPVLGP
201 VR\GPFPIIV
This peptide was digested using trypsin at a level of 40
pmol, and the crude digest analyzed using MALDI,
with DHB as the matrix. Each spectrum was obtained
from 1/8 of the total digestion solution (corresponding to
digestion products from 5 pmol of the protein). A relevant
portion of the resulting mass spectrum, in which frag-
ments containing approximately 25 residues are observed,
is shown in Figure 4a. The largest peaks in the spectrum
are (average values are listed for all) m/z 3723.5, which
represents the protonated form of fragment {177–209}, and
m/z 4485.4 representing {170–209}. Neither is phosphory-
lated. The minor peaks at m/z 3124 {1–25} and m/z 3479.4
{1–28} both represent peptides that contain the four phos-
phorylated serine residues at positions 15, 17, 18, and 19.
Figure 4b shows the MALDI analysis of the same tryptic
digest after the addition of (NH4)2HCit. Note the substan-
tial increase in the peaks representing the phosphorylated
components. They become the most intense peaks in the
spectrum.
It should be noted that ammonium bicarbonate was
used as a buffer in the digestion. This volatile buffer
was removed by application of a vacuum to the sample
for 12 h before the MALDI matrix was added. This
allowed the spectrum in Figure 4a to be obtained. Then,
additives were introduced to obtain the spectrum in
Figure 4b. This raises an interesting observation. One
approach following digestion is separation using
HPLC, and analysis of the fractions using MALDI. If
this is done to simplify the mixtures analyzed and to
avoid possible suppression effects, the ammonium
buffer salt is separated from the peptides, and the
response for phosphopeptides is low. If the digestion
products are analyzed directly, and ammonium salts
are used as buffers, one may be more likely to detect the
phosphorylated components because of the influence of
ammonium ions.
An additional advantage of enhanced response, as
displayed in Figure 4b, is that the phosphopeptide
peaks are now sufficiently intense that PSD mass spec-
tra [1, 34, 35] can be obtained with a good S/N ratio.
Annan and Carr [1] have shown that the PSD spectra of
singly modified peptides phosphorylated at serine and
threonine eliminate H3PO4 (loss of 98 u), with a rela-
tively minor loss of HPO3 (280 u). For phosphorylated
tyrosine, loss of HPO3 dominates. If the ions at m/z
3124, {1–25} H1, in the linear spectrum of the unfrac-
tionated tryptic digest mixture are subjected to PSD
analysis, the spectrum that results is shown in Figure 5.
The spectrum shows four consecutive losses of phos-
phate groups, confirming its assignment.
The fragmentation processes leading to the peaks
observed in Figure 5 warrant comment. Loss of multiple
phosphates must be sequential, and possible scenarios
for forming the observed ions are presented in Figure 6.
The tetraphosphorylated precursor ion is at m/z 3124;
all four phosphorylation sites are serine residues. Loss
of 98 yields the peak at 3026. There is no peak corre-
sponding to HPO3 loss at m/z [3124 2 80], and there
could be two reasons for this. The first may be that,
when the internal energy content of the ion is high, the
process leading to loss of H3PO4 has a higher rate than
that leading to loss of HPO3, so the former is observed
exclusively. Alternatively, the ion with m/z 3044 may
be formed but may dissociate completely, to undergo
further eliminations. We suggest that the former expla-
nation is correct. Analysis of the entire spectrum shows
Figure 4. MALDI mass spectra of a tryptic digestion mixture
from 5 pmol of b-casein in (a) 2,5-dihydroxybenzoic acid and (b)
2,5-dihydroxybenzoic acid with addition of diammonium citrate.
The peaks marked by an asterisk represent phosphorylated com-
ponents.
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that phosphate elimination via loss of 98 dominates,
which is consistent with Carr’s observation for phos-
phoserine [1]. However, all four phosphates are obvi-
ously not lost as H3PO4. Three forms of the completely
dephosphorylated ions are present. The peak at m/z
2732 corresponds to [3124 2 4(98)]1, m/z 2749 corre-
sponds to [3124 2 3(98) 2 80]1 and m/z 2768 to
[3124 2 2(98) 2 2(80)]1. As successive eliminations oc-
cur, loss of 80 becomes more competitive with loss of
98. With each phosphate loss, internal energies drop
and relative rates change. For the completely dephos-
phorylated forms, relative intensities and mass-to-
charge ratio values suggest that 82% of the phosphates
were eliminated as H3PO4 and 18% as HPO3. Also of
note, there is a small peak at m/z 3106, which corre-
sponds to [3124 2 H2O]
1. This ion also appears to lose
phosphates, and is responsible for the low intensity
peaks at mass-to-charge ratio values below those of the
[3124 2 n(98)]1 peaks, such as m/z 3008, [(3124 2
H2O) 2 98]
1. In the context of the PSD experiments, we
note a publication by Gorman et al. [36], introducing a
mixture of 2,6-dihydroxyacetophenone and diammo-
nium citrate as a MALDI matrix. This matrix was
shown to decrease fragmentation because of phosphate
loss for a phosphopeptide, relative to what is observed
using a-cyano-4-hydroxycinnamic acid as the MALDI
matrix. The ammonium salt may have been playing a
key role in this experiment.
Phosphate elimination occurs at a higher rate than
skeletal bond cleavage, and the available internal en-
ergy is apparently used to eliminate multiple phosphate
groups rather than from sequence-specific fragment
ions. This has been observed previously for a triphos-
phorylated peptide by MALDI [1] and a pentaphospho-
rylated peptide using electrospray [37]. Thus, whereas
the PSD spectrum indicates the number of phosphates
present, it does not also yield the sequence. The sample
should be treated with alkaline phosphatase, and the
sequence determined from PSD analysis of the non-
phosphorylated form. Alternatively, the sample may be
treated with base resulting in b-elimination of H3PO4.
This may aid in identifying the location of the phos-
phate group as well as obtaining sequence specific
fragment ions [37].
Influence of (NH4)2HCit on the MALDI Mass
Spectra of Phosphopeptides: Mechanistic
Considerations
To understand the role of diammonium citrate in this
experiment, consider the order in which compounds
precipitate from the matrix target solution as the vola-
tile solvents evaporate. To do so, initial concentrations
were defined, and the volume decreased in regular
steps. At each step, new concentrations were computed,
and the products of concentrations were computed to
determine the volumes at which solubility limits were
reached. This exercise contains a number of approxima-
tions and assumptions, and is meant to serve a simple
purpose rather than to be a rigorous description of the
system. In the experiment described, the initial solution
has a volume of 3 mL, and is described in the sidebar of
Figure 7. It contains matrix molecules, in which it is
nearly saturated. It contains diammonium citrate. As-
sume that NaCl is present. To show the role that the
additive can play, we will assume that NaCl is intro-
duced with the matrix because it is a common impurity
Figure 5. PSD spectrum of m/z 3124, a tryptic digestion product
of b-casein containing four phosphate groups (p).
Figure 6. The mass-to-charge ratio values of observed fragment
ions resulting from losses of 80 and 98 Da from the tetraphospho-
rylated peptide at m/z 3124. The mass-to-charge ratio values in
parentheses represent peaks not detected. The loss of 98 Da
corresponds to elimination of H3PO4; loss of 80 indicates loss of
HPO3.
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in matrices and peptides [38]. The 4-HCCA matrix is
provided from the manufacturer as 97% pure, so we
will make the extreme assumption that the remaining
3% is NaCl, leading to the initial [Na1] of approxi-
mately 0.7 mM. There is also a phosphopeptide present.
Information on the solubilities of phosphopeptides is
not readily available, so for simplicity we will consider
the phosphopeptide as a phosphate ion. A picomole of
phosphopeptide in a solution of 3 mL results in a
solution which is initially 0.3 mM in phosphopeptide
(phosphate).
Figure 7 suggests how concentrations change as
solvent evaporates and volume decreases. When the
volume decreases by a factor of 3, the solution becomes
saturated in matrix, and precipitation of matrix crystals
begin. This is indicated as point A in Figure 7. Further
reduction in volume should not yield increases in
matrix concentration—it will remain constant and for-
mation of solid matrix will continue. Of note is the pH
of the solution from which other compounds will
precipitate. The pH of a solution saturated in the matrix
4-HCCA was measured, yielding a value of 2.45. At this
value, most of the phosphopeptide is expected to be in
the form of R–OPO3H
2; hence, the form of phosphate
used in the calculation is H2PO4
2.
As solvent evaporates further, the species with the
highest concentrations become Na1, NH4
1, and HCit22.
For the initial concentrations used, and considering the
Ksp [39] of Na2HCit to be 43 (in water) and that for
(NH4)2HCit to be larger (345), Na2HCit will precipitate
first, at the point indicated by B in Figure 7. This process
has two consequences. Once the point of saturation is
reached, [Na1] and [HCit22] will remain constant as
further solvent evaporates. Also, it indicates that citrate
is effective in “capturing” sodium ions and forming a
precipitate. Thus, Na1 ions can be effectively removed
during the solvent evaporation process by the HCit22
ions. Further evaporation increases the ammonium ion
concentration to the point where diammonium citrate
precipitates, indicated by C in Figure 7, limiting further
increases in ammonium ion concentration. The last
ionic species in solution is the phosphate (phosphopep-
tide), which can precipitate in the high concentration of
ammonium ions as the ammonium salt, which degrades
at some later point in the experiment via ammonia loss as
explained previously. In this calculation, concentrations
are never achieved to allow precipitation of sodium phos-
phate, the phosphate only precipitates as the ammonium
salt [Ksp (NaH2PO4) 5 26, Ksp (NH4H2PO4) 5 10]. Al-
though the calculation can be carried to very small
solution volumes, there is a point where the system can
no longer be considered as a solution—where there are
an insufficient number of solvent molecules per solute
molecule. Thus, the sample becomes a solid with par-
tially hydrated species at a volume around points B/C.
Thus, it is probably not the Ksp values of NaH2PO4 and
NH4H2PO4 that determine which cation is captured by
the phosphate group; this is probably reflecting the
relative availability/concentrations of the ammonium
ions vs. sodium ions.
Obviously, the calculation resulting in Figure 7 is not
rigorous—it was done to assist in considering possibil-
ities. Concentrations, not activities, were used, and ionic
strengths can become considerable during solvent
evaporation. Equilibrium (aqueous) values are of lim-
ited use in such a system when volatile solvents are
rapidly evaporating. The mixed solvent system presum-
ably changes composition during evaporation. Trap-
ping of analyte and salt molecules, in neutral and
charged forms, in precipitating matrix crystals is not
considered but obviously takes place [40–43].
In such a calculation, it is difficult to make general
statements concerning the behavior of polypeptides/
proteins. Solubilities of proteins in aqueous solutions
vary enormously [44]. Solubilities can be enhanced with
mixed solvents, acids, salts, and other solubilizing
agents. Also, proteins can “salt out” at high salt concen-
trations, notably when ammonium salts are used [44,
45]. Ammonium sulfate has been used to help precipi-
tate nonphosphorylated hydrophobic peptides prior to
MALDI analysis [33]. Peptides frequently have solubil-
ities on the order of tens of mg/mL. For example,
angiotensin I, angiotensin III, and myoglobin have
aqueous solubilities of 10, 25, and 20 mg/mL, respec-
tively [46]. Phosphorylation leads to an increase in
solubility in some cases [2, 47].
The calculation suggests a useful model. As solvent
evaporates, matrix first begins to precipitate. If sodium
ions are present in a sufficient amount, citrate ions can
form sodium citrate. This will limit sodium ion concen-
tration. The phosphopeptide can then interact with
ammonium ions in the later stages of evaporation,
Figure 7. Plot of concentrations of ions vs. volume of an evapo-
rating sample droplet containing matrix, a phosphopeptide, a
sodium salt, and diammonium citrate. The volumes at which
precipitation of each solid would occur is indicated by points A, B,
C, and D.
42 ASARA AND ALLISON J Am Soc Mass Spectrom 1999, 10, 35–44
leading to the ultimate “neutralization” of the phos-
phate group(s). Also of note, ammonium acetate fre-
quently was found to be as effective as ammonium
citrate as a matrix additive. The Ksp for sodium acetate
is smaller than that for ammonium acetate, analogous to
the relationship for the citrate salts, so in such systems,
acetate can limit the role of sodium ions as does citrate.
Such calculations can be particularly instructive when
ionic species are involved.
Conclusions
The use of diammonium citrate as an additive in the
MALDI matrix assists in the analysis of phosphopep-
tides as it does for oligonucleotides, presumably by
lowering the charge state of the analyte, allowing for
desorption to occur. The approach is simple, has real
utility, and can be used in a variety of ways. For
example, suppose a valuable polypeptide sample is
subjected to MALDI analysis for a molecular weight
determination, and no peak is detected. It may be
phosphorylated, and is exhibiting a poor response. In
this case, the matrix/analyte target can be removed
from the instrument, and 1–2 mL of the diammonium
citrate solution added. It has been verified that the
target will redissolve and new crystals will be formed,
incorporating the additive. This may lead to successful
detection, and would suggest that the analyte may be
phosphorylated. If so, the additive increases the prob-
ability that sufficient numbers of ions will be available
to perform further analyses, to determine if phosphate
groups are present, and how many. The use of this
simple additive will allow investigations of more highly
phosphorylated polypeptides to establish their frag-
mentation patterns, and to establish the maximum
number of phosphate groups that could be determined
by PSD or CAD.
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